These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1952869)

  • 1. In vitro susceptibility of Brucella melitensis to antibiotics.
    Rubinstein E; Lang R; Shasha B; Hagar B; Diamanstein L; Joseph G; Anderson M; Harrison K
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1925-7. PubMed ID: 1952869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining in vitro synergistic activities of tigecycline with several other antibiotics against Brucella melitensis using checkerboard and time-kill assays.
    Aliskan H; Can F; Demirbilek M; Colakoglu S; Kilic S; Arslan H
    J Chemother; 2009 Feb; 21(1):24-30. PubMed ID: 19297268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of in vitro activities of tigecycline and various antibiotics against Brucella spp.
    Ozhak-Baysan B; Ongut G; Ogunc D; Gunseren F; Sepin-Ozen N; Ozturk F; Aktepe OC; Gultekin M
    Pol J Microbiol; 2010; 59(1):55-60. PubMed ID: 20568531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro efficacy of several antimicrobial combinations against Brucella canis and Brucella melitensis strains isolated from dogs.
    Mateu-de-Antonio EM; Martín M
    Vet Microbiol; 1995 Jun; 45(1):1-10. PubMed ID: 7653024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates of Brucella melitensis compared with those of cefoxitin, rifampin, tetracycline, and co-trimoxazole.
    Gutiérrez Altés A; Díez Enciso M; Peña García P; Campos Bueno A
    Antimicrob Agents Chemother; 1982 Mar; 21(3):501-3. PubMed ID: 6980624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis.
    Bosch J; Liñares J; López de Goicoechea MJ; Ariza J; Cisnal MC; Martin R
    J Antimicrob Chemother; 1986 Apr; 17(4):459-61. PubMed ID: 2940209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro synergistic effects of a short cationic peptide and clinically used antibiotics against drug-resistant isolates of Brucella melitensis.
    Mohammadi Azad Z; Moravej H; Fasihi-Ramandi M; Masjedian F; Nazari R; Mirnejad R; Moosazadeh Moghaddam M
    J Med Microbiol; 2017 Jul; 66(7):919-926. PubMed ID: 28699872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.
    Bayram Y; Korkoca H; Aypak C; Parlak M; Cikman A; Kilic S; Berktas M
    Int J Med Sci; 2011 Mar; 8(3):198-202. PubMed ID: 21448305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis.
    Khan MY; Dizon M; Kiel FW
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1409-10. PubMed ID: 2802568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region.
    Tanyel E; Coban AY; Koruk ST; Simsek H; Hepsert S; Cirit OS; Tulek N
    Saudi Med J; 2007 Aug; 28(8):1239-42. PubMed ID: 17676210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China.
    Liu ZG; Di DD; Wang M; Liu RH; Zhao HY; Piao DR; Zhao ZZ; Hao YQ; Du YN; Jiang H; Cui BY; Xia XZ
    BMC Infect Dis; 2018 Jan; 18(1):43. PubMed ID: 29338693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Brucella melitensis to fluoroquinolones.
    Qadri SM; Akhtar M; Ueno Y; al-Sibai MB
    Drugs Exp Clin Res; 1989; 15(10):483-5. PubMed ID: 2632216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [E-test susceptibility results of brucella strains for streptomycin, rifampicin, ciprofloxacin and tetracycline].
    Sengöz G; Yaşar KK; Kutlu SB; Durdu YB; Ozdemir R; Nazlican O
    Mikrobiyol Bul; 2006 Jul; 40(3):265-8. PubMed ID: 17001857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of lomefloxacin against Brucella melitensis.
    Qadri SM; al-Sedairy S; Ueno Y
    Diagn Microbiol Infect Dis; 1990; 13(3):277-9. PubMed ID: 2383977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis.
    Kilic S; Dizbay M; Cabadak H
    J Chemother; 2008 Feb; 20(1):33-7. PubMed ID: 18390405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of
    Shevtsov A; Syzdykov M; Kuznetsov A; Shustov A; Shevtsova E; Berdimuratova K; Mukanov K; Ramankulov Y
    Antimicrob Resist Infect Control; 2017; 6():130. PubMed ID: 29299304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The canonical Brucella species-host dependency is changing, however, the antibiotic susceptibility profiles remain unchanged.
    Celik E; Kayman T; Buyuk F; Gulmez Saglam A; Abay S; Akar M; Karakaya E; Balkan Bozlak CE; Coskun MR; Buyuk E; Celebi O; Sahin M; Saticioglu IB; Durhan S; Baykal A; Ersoy Y; Otlu S; Aydin F
    Microb Pathog; 2023 Sep; 182():106261. PubMed ID: 37488036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of in vitro susceptibilities of Brucella spp. strains against 11 different antibacterial gents isolated from blood cultures].
    Keşli R; Bilgin H; Yılmaz H
    Mikrobiyol Bul; 2017 Jul; 51(3):260-268. PubMed ID: 28929962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis.
    López-Merino A; Contreras-Rodríguez A; Migranas-Ortiz R; Orrantia-Gradín R; Hernández-Oliva GM; Gutiérrez-Rubio AT; Cardeñosa O
    Scand J Infect Dis; 2004; 36(9):636-8. PubMed ID: 15370648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sensitivity of Brucella melitensis to various antibiotics, drug preparations and their combinations].
    Samarina IV; Taran IF; Proskurina VA; Liapustina LV
    Antibiot Khimioter; 1991 Apr; 36(4):22-3. PubMed ID: 1892428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.